To Switch or Not to Switch: Patient Case Discussions on Integrating Biosimilars in Multiple Sclerosis Care

What are the main indicators that a patient with multiple sclerosis (MS) can be switched to a biosimilar? Credit available for this activity expires: 5/31/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000864?ecd=bdc_podcast_libsyn_mscpedu